National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions--United States, 2003.
National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions--United States, 2003.
复制标题
DOI：
10.1001/jama.297.15.1649
复制
发表时间：
2007-01
期刊：
影响因子：
--
通讯作者：
E. Yelin;M. Cisternas;A. Foreman;D. Pasta;L. Murphy;C. Helmick
中科院分区：
文献类型：
--
作者：
E. Yelin;M. Cisternas;A. Foreman;D. Pasta;L. Murphy;C. Helmick
在美国，关节炎是导致残疾的主要原因，可能会限制受影响的人走几个街区或爬一段楼梯。利用医疗支出小组调查（MEPS）的数据，疾病预防控制中心分析了2003年美国由关节炎和其他风湿性疾病（AORC）引起的全国和各州的直接成本（即医疗支出）和间接成本（即收入损失）。本报告描述了该分析的结果，该分析表明，2003年美国的主动脉修复总成本约为1280亿美元（直接成本为808亿美元，间接成本为470亿美元），相当于2003年美国国内生产总值的1.2%。按州/地区划分，该项目的总成本从哥伦比亚特区的2.255亿美元到加州的121亿美元不等。自1997年以来，可归因于急性动脉粥样硬化的总费用大幅增加，由于人口老龄化以及肥胖和缺乏运动的人数增加，预计这种增加将继续下去。这些发现表明，需要更广泛地实施有效的公共卫生干预措施，如关节炎和慢性疾病自我管理计划，这可以减少主动脉粥样斑块患者的医疗支出。
Arthritis is the leading cause of disability in the United States, potentially limiting affected persons from walking a few blocks or climbing a flight of stairs. Using Medical Expenditure Panel Survey (MEPS) data, CDC analyzed national and state-specific direct costs (i.e., medical expenditures) and indirect costs (i.e., lost earnings) attributable to arthritis and other rheumatic conditions (AORC) in the United States during 2003. This report describes the results of that analysis, which indicated that, in 2003, the total cost of AORC in the United States was approximately 128 billion dollars (80.8 billion dollars in direct and 47.0 billion dollars in indirect costs), equivalent to 1.2% of the 2003 U.S. gross domestic product. Total costs attributable to AORC, by state/area, ranged from 225.5 million dollars in the District of Columbia to 12.1 billion dollars in California. Total costs attributable to AORC have increased substantially since 1997, and that increase is expected to continue because of the aging of the population and increases in obesity and physical inactivity. These findings signal the need for broader implementation of effective public health interventions, such as arthritis and chronic disease self-management programs, which can reduce medical expenditures among persons with AORC.